AIDS vaccine Current Events | AIDS vaccine News
|
| Page
1 of
48 |
958 Results |
|
|
|
Sort By:
Page Views | Date |
HIV isolate from Kenya provides clues for vaccine design
Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine. view more (2008-01-03)
India continues to progress in AIDS vaccine development efforts
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the... view more... (2008-08-18)
WORLD AIDS SERIES: BREAKING THE SILENCE---SETTING REALISTIC PRIORITIES FOR AIDS CONTROL (p 49)
'The AIDS pandemic is a human tragedy that is threatening development in the poorest countries. There is no cure or vaccine, but the tools to control the epidemic already exist. Nevertheless, there are few examples of national AIDS control programmes that have had an impact on the epidemic. We (an economist and a planner) attribute this to the... view more... (2000-06-28)
Unique partnership brings new hope for vaccine to combat HIV
Under embargo for 10.30 GMT Thursday 13 December 2001 view more (2001-12-12)
An HIV Vaccine is within reach
An effective, affordable, and accessible HIV vaccine is 7-10 years away, according to scientists at the Medical Research Council of South Africa, in this week's BMJ. However, its success depends on a complex interplay of politics, science, and public-private partnerships. view more (2002-01-23)
UCLA scientists discover immune response to HIV differs, even in identical twins
In findings illustrating the difficulty of developing an AIDS vaccine, UCLA AIDS Institute researchers report the immune systems in two HIV-positive identical twins responded to the infection in different ways. view more (2005-12-07)
Global HIV Vaccine Enterprise Announces Strategic Plan
A Much-Needed Shot in the Arm for HIV Vaccine Development International efforts towards developing a vaccine against HIV infection have been given a much-needed boost by the publication today of the Global HIV/AIDS Vaccine Enterprise's scientific strategic plan, published online in the freely available, open-access global health journal PLoS... view more... (2005-01-10)
"EuroVacc 02" HIV Vaccine trial begins
The European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005. These vaccines are based on HIV subtype C, which is prevalent in China, India and sub-Saharan... view more... (2005-02-16)
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily... view more... (2008-08-28)
The release of new data from the HVTN 502 HIV vaccine study
The new analyses revealed today from the STEP HIV vaccine clinical trial are both disappointing and puzzling. At this time, the data offer no clear explanations as to why the vaccine showed no measurable efficacy or why among individuals with background immunity to the adenovirus vector, there were more HIV infections in the vaccinees as compared... view more... (2007-11-08)
IAVI statement on new analysis of STEP large-scale AIDS vaccine trial
The International AIDS Vaccine Initiative (IAVI) issued the following statement from its President and CEO, Dr. Seth Berkley, following the release of the first analysis of the entire study population from a late-stage AIDS vaccine trial, known as the STEP study. view more (2007-11-08)
Novel vaccine approach offers hope in fight against HIV
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers. view more (2009-05-18)
Jefferson scientists find rabies-based vaccine could be effective against HIV
Rabies, a relentless, ancient scourge, may hold a key to defeating another implacable foe: HIV. Scientists at Jefferson Medical College in Philadelphia have used a drastically weakened rabies virus to ferry HIV-related proteins into animals, in essence, vaccinating them against an AIDS-like disease. view more (2007-04-04)
Combating anthrax: Results of study published this month as researchers look for a better vaccine
A new study published this month by a Saint Louis University vaccine researcher scrutinizes what in the future could be an alternative to the presently available anthrax vaccine. view more (2006-08-15)
AIDS surpasses black death as deadliest disease in history
In terms of illness and death, AIDS is worse than the Black Death of the 14th century. Ninety five per cent of new infections of HIV are in the world's poor countries and heterosexual transmission is responsible for most of these, reports Peter Lamptey, in this week's BMJ. view more (2002-01-23)
Survey uncovers surprising attitudes towards HIV vaccine research
A survey of U.S. adults has found that a majority believe that HIV vaccines are the best hope for controlling the global AIDS epidemic and are confident such vaccines can be made. view more (2005-08-09)
HIV Adapts to 'Escape' Immune Response
The human immunodeficiency virus (HIV) adapts so well to the body's defense system that any successful AIDS vaccine must keep pace with the ever-changing immunological profile of the virus, according to researchers at the University of Alabama at Birmingham (UAB) and the University of Oxford in England. view more (2009-03-02)
AIDS vaccine research offers new insights on survival
New insights into how a subpopulation of helper T-cells provides immunity and promotes survival following infection with an AIDS-like virus offer a new means of predicting an AIDS vaccine's effectiveness, a discovery that could help scientists as they test these vaccines in clinical trials. view more (2006-06-12)
EDCTP welcomes G8 support for HIV/AIDS vaccine development
On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to accelerate HIV vaccine development by enhancing coordination, information sharing, and global collaboration. The EDCTP is pleased to see this expression of support and... view more... (2004-06-11)
Quality not quantity important for immune response to HIV
When it comes to an immune response against HIV, research funded by the Wellcome Trust in the UK and the National Institutes of Health in the US has found that bigger is not necessarily better, contrary to conventional medical wisdom. view more (2006-12-18)
|
|
| Page
1 of
48 |
958 Results |
|
|
|
Sort By:
Page Views | Date |
|
